# China NMPA Drug Inspection - Yunnan Longfa Pharmaceutical Co., Ltd. - Pudilan Anti-inflammatory Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/yunnan-longfa-pharmaceutical-co-ltd/1d00bbd8-60fa-4566-9822-1046a8bf1e19/
Source feed: China

> China NMPA drug inspection for Yunnan Longfa Pharmaceutical Co., Ltd. published July 16, 2021. Drug: Pudilan Anti-inflammatory Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Yunnan Provincial Drug Administration issued the second issue of the 2021 Drug Quality Bulletin.
- Company Name: Yunnan Longfa Pharmaceutical Co., Ltd.
- Publication Date: 2021-07-16
- Drug Name: Pudilan Anti-inflammatory Tablets
- Inspection Finding: Compliant
- Action Taken: Supervision and spot checks

Company: https://www.globalkeysolutions.net/companies/yunnan-longfa-pharmaceutical-co-ltd/a64e9b15-3b5a-46fd-81e5-473060f4b307/